Completed PHASE4 INTERVENTIONAL 2-arm NCT00564213

Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds (BQ-01-07-ARVO)

Sponsor: Instituto de Olhos de Goiania

Interventions PRK and a single intraoperative topical application of mitomycin C 0.02% for 15 seconds

Updated 5 times since 2017 Last updated: Nov 25, 2008 Started: Mar 31, 2005 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates High Myopia and is currently completed. Instituto de Olhos de Goiania leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Olhos de Goiania

Data source: Instituto de Olhos de Goiania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.